OncoCyte Corporation (OCX)

OncoCyte Revenue

In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth. Revenue in the quarter ending December 31, 2023 was $314.00K with 14.60% year-over-year growth.

• Revenue (ttm): $1.50M
• Revenue Growth: +56.89%
• P/S Ratio: 14.64
• Revenue / Employee: $34,953
• Employees: 43
• Market Cap: 22.01M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.